Healthcare -
Biotechnology - NASDAQ - US
$ 3.28
3.8 %
$ 281 M
Market Cap
-0.86
P/E
Price Target
Average
79.12%
Revenue Forecast
Estimate
--57.55%
EBIT
Estimate
--16.61%
Net Income
Estimate
--38.18%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Amylyx Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for AMLX of $5.88 , with forecasts ranging from
a
low of
$3 to a high of $11 .
AMLX Lowest Price Target
Wall Street Target
3 USD
-8.54%
AMLX Average Price Target
Wall Street Target
5.88 USD
79.12%
AMLX Highest Price Target
Wall Street Target
11 USD
235.37%
REVENUE FORECAST
Revenue Forecast Chart AMLX
EBIT FORECAST
EBIT Forecast Chart AMLX
NET INCOME FORECAST
Net Income Chart AMLX